The IRA Changed Your 340B Math. Now What?

Fortify Your Mission: Pharmacy Program Strength in an Era of 340B Complexity

Market forces are compressing 340B margins right now.

Join NuvemRx leaders virtually on Wed. April 22 at 1pm ET / 10am PT 
for a look at what’s changing, where growth is hiding, and what 800+ covered entities are doing to stay ahead.

You’ll leave knowing where you stand—and what to do next.

NuvemRx Crest Design (2)

Speaker Segments

headshot_2_720

Scott Seidelmann
CEO, NuvemRx

These IRA forces are rewriting 340B economics. What they mean for your program—and a new vision for what comes next.

8

Melissa Opraseuth

Chief Clinical Officer, NuvemRx

Existing margins are shrinking. See where the untapped growth is hiding—in prescriptions you’re already entitled to.

6

Charlie Hirner

SVP of Mission Control, NuvemRx

What 800+ covered entities reveal about IRA impact—and the practical insights your team can’t generate alone.